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Abstract: Autophagy failure is implicated in age-related human disease. A decrease in the rate of
protein degradation through the entire autophagy pathway, i.e., autophagic flux, has been associated
with the onset of cellular proteotoxity and cell death. Although the precision control of autophagy
as a pharmacological intervention has received major attention, mammalian model systems that
enable a dissection of the relationship between autophagic flux and pathway intermediate pool sizes
remain largely underexplored. Here, we make use of a micropattern-based fluorescence life cell
imaging approach, allowing a high degree of experimental control and cellular geometry constraints.
By assessing two autophagy modulators in a system that achieves a similarly raised autophagic
flux, we measure their impact on the pathway intermediate pool size, autophagosome velocity,
and motion. Our results reveal a differential effect of autophagic flux enhancement on pathway
intermediate pool sizes, velocities, and directionality of autophagosome motion, suggesting distinct
control over autophagy function. These findings may be of importance for better understanding the
fine-tuning autophagic activity and protein degradation proficiency in different cell and tissue types
of age-associated pathologies.
Keywords: autophagic flux; vesicle dynamics; autophagosome; autolysosome; lysosome; pool size;
velocity; displacement; micro-pattern
1. Introduction
The accumulation of toxic protein aggregates in neuronal cells is a major hallmark for brain
aging. A tightly controlled molecular mechanism governing proteostasis is required to promote
neuronal health, thereby impacting directly on cell viability and function [1,2]. Autophagy is a key
protein degradation pathway that is crucial in not only degrading long-lived proteinaceous cargo,
but also in finely tuning neuronal metabolism and activity with the cell’s metabolic demands [3,4].
Two major types of autophagic mechanisms participate in this quality control system. Macroautophagy
(hereafter referred to as autophagy) primarily targets aggregated and misfolded proteins through
autophagosomes for lysosomal degradation, while chaperone-mediated autophagy (CMA) operates
through specifically targeted cytosolic proteins that are delivered to lysosomes via chaperones.
Importantly, the rate of protein degradation through the entire autophagy pathway, i.e., autophagic flux,
indicates the activity of this process [5] and has received major attention, since its decline contributes
to cellular toxicity, degeneration, and aging.
It has long been recognized that mammalian tissues are characterized by a distinct, tissue-specific
abundance of LC3 protein [6] which is also distinctively responsive to metabolic perturbations [7].
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Moreover, recent advances in measuring autophagic activity, or autophagic flux, i.e., the rate of
protein degradation through autophagy, have demonstrated that the basal rate of protein degradation
under control conditions differs substantially between tissue types [8], allowing to rank organs
and tissues according to their autophagic activity. In this context, it is of particular importance
to note that some tissues are characterized by a particularly high autophagic flux, indicating a
very efficient protein cargo clearing system [9], which declines in ageing and degeneration [10].
Autophagy dysfunction leads to protein aggregation, which enhances toxicity of the intracellular
microenvironment, including mitochondrial quality control, further contributing to cellular pathology.
Also, cancer cells are characterized by a heightened basal autophagic activity and by a change in
their autophagy proficiency [11]. It is therefore not surprising that the pharmacological modulation
of autophagy has attracted considerable attention as a potential therapeutic target in pathologies
associated with autophagy dysfunction [12] and a multitude of drug libraries is being screened for
most effective autophagy inducing or inhibiting properties [13]. A primary focus in the context of
neurodegeneration and aging is thereby, to better identify the autophagy defect, to offset autophagy
dysfunction and to enhance protein clearance by inducing autophagy [14], in order to preserve
neuronal cell viability. Similarly, in many cancer types, clinical trials are on the way with the aim to
either robustly or sequentially [15] induce the autophagic system to inherently lethal or sensitizing
levels, or to inhibit the pathway, so as to sensitize to cell death induction in combination with a
chemotherapeutic agent [16].
However, the level of the most desirable level of autophagic activity, related to the given pathology,
i.e., the most suitably level of protein clearance, remains thus far largely unclear. This is, at least in part,
due to the challenge of measuring autophagic activity precisely and controlling pathway intermediate
steady-state pool sizes [17]. Hence, the precision control of autophagy, to better tune the autophagic
machinery and its activity, is highly desirable, however, remains poorly assessed. How far could
autophagy be functionally exploited, without leading to vesicular crowding and organelle traffic
failure? Critical in this context is the role of the microtubule network, its carrying capacity, to deliver
vesicular cargo such as autophagosomes, ATP dependently to the perinuclear region, where fusion
with lysosomes is facilitated. Although such autophagosome vesicle dynamics have been described
in the past [18], the relationship between autophagic flux, pathway intermediates and their pool
sizes and well velocities remain largely unclear. In particular, it is not known whether enhanced
autophagic flux will lead to an increase in autophagosome vesicle velocity or displacement, thereby
enhancing autophagy function, or whether autophagy vesicle dynamics are equally dependent on
mTOR dependent or independent autophagy induction. Finally, although it has recently been revealed
that hyperosmotic and mechanical stress exerts a degree of control on autophagic activity [19] it
remains unknown to what extent geometric constraints, such as cellular size and shape, may affect
the response to autophagy modulation. The rational of this study was, therefore, to utilize a basic
mammalian model system, allowing to assess two autophagy inducing drugs and to dissect the
relationship between autophagic flux and vesicle dynamics. To enhance experimental control and
to include geometry constraints, allowing to assess the contribution of tubulin organisation in this
context, micropatterning was additionally utilized.
The above findings strongly demand the integration of an experimental approach that allows
to describe autophagic flux and pathway intermediates in a highly controlled cellular environment,
so as to better understand vesicle dynamics and autophagosome/lysosome fusion behaviour, as an
indication of functional protein degradation through autophagy. Recent advances in autophagic
flux assessment and control of pathway intermediates [17,20,21] and enhanced approaches of
micropatterning [22] provide a new level of control over autophagic activity as well as geometry
constraints, allowing to dissect pathway intermediates, their velocities and tubulin structure with high
precision. In this context, mouse embryonic fibroblasts, in particular, have been utilized as suitable
mammalian cell model systems [8,21].
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Therefore, the aims of this study were to firstly establish conditions of precision-controlled
autophagic flux, assessing two known autophagy modulators, spermidine and rapamycin, using a
concentration that achieves similarly raised autophagosome flux. Taking advantage of a precisely
determined autophagosome flux, we next assessed the corresponding intracellular pathway intermediate
pool sizes, i.e., autophagosome, autolysosomes and lysosomes. Secondly, we aimed to determine whether
manipulation of the autophagic pathway with known fluxes leads to a change in autophagosome
velocity, displacement and directionality, as an indication for successful cargo delivery and functional
autophagy. Finally, by implementing a micropatterning approach, in order to maximize control over
cellular morphology, we aimed to resolve the role of physical constraints, cellular shape and the tubulin
network geometries on autophagy vesicle dynamics and hence autophagy function. Our results reveal a
surprising differential effect of autophagic flux enhancement on autophagosome velocity, position and
motion as well as displacement when comparing mTOR dependent and mTOR independent pathway
activation, with a distinct impact of cellular geometry, blunting autophagosome velocity and redirecting
autophagosome position. These data highlight distinct cellular responses of autophagy enhancing
drugs and reveal an additional level of control through cellular morphology and shape, requiring
careful autophagic flux titration in a cell and tissue specific manner when screening autophagy
modulating drugs for clinical translation. The results further suggest that cellular shape and tubulin
network geometries, as well as a defined tissue microenvironment, may impact autophagy function,
by distinctly affecting vesicle motion, fusion and hence the cell’s protein degradation proficiency.
2. Materials and Methods
2.1. Cell Culture
Mouse Embryonic Fibroblast (MEF) cells that stably express GFP light chain 3 (LC3) protein
(a kind gift from Prof. Noboru Mizushima, Tokyo University, Japan) were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) (Life Technologies, 41965-039) supplemented with 10% fetal bovine
serum (Biochrom, Berlin, Germany, S-0615), 1% Penicillin-Streptomycin (ThermoFisher, Johannesburg,
South Africa, 15140148); 100 U/mL of penicillin and 100 µg/mL of streptomycin, and maintained
in a humidified atmosphere in the presence of 5% CO2 at 37 ◦C. The sub-culturing of MEF cells
involved trypsinisation (Life Technologies, 25200-072) to dissociate adherent cells from the flask.
Following trypsinisation, cells were collected in a 50 mL falcon tube (Biocom Biotech, Centurion,
South Africa, 50050) and supplemented DMEM was added in a 2:1 ratio. Cells were centrifuged
(Merck Millipore, Johannesburg, South Africa, Eppendorf Centrifuge 5804 R) at 1500 rpm for three
minutes at room temperature. The supernatant was discarded, and cells re-suspended in DMEM.
Cells were seeded in either culturing flasks (Porvair, WhiteSci, Brackenfell, South Africa, 500030), in
an 8-chamber cover slip-based dish (Nunc Lab-Tek, Thermo Scientific, Johannesburg, South Africa,
155411PK) or a micropatterned slide for experimental purposes.
2.2. Fabrication of Micropatterned Slides
Fibronectin disc shapes were micropatterned on glass using deep UV as described by Carpi et al. [23]
with some modifications. The glass coverslip was washed with 70% ethanol, dried using a dry-oven
and then silanizated by deep UV (185 nm) illumination for 10 min using a UVO cleaner (Jelight, model
18). Thereafter the glass slide was passivated by placing it on top of a drop of PLL-g-PEG solution
(0.1 mg/mL PLL(20)-g[3.5]-PEG(2) (Surface Solutions, Zurich, Switzerland), 10 mM Hepes, pH 7.4.) on
a sheet of parafilm with the activated face in contact with the PLL-g-PEG. The coverslip was incubated
with the PLL-g-PEG solution for one hour at room temperature. The coverslip was then washed for
2 min in PBS and rinsed for 2 min in millipore water. A quartz photomask with the edged patterns
was used to transfer the patterns onto the PLL-g-PEG layer. The mask was manufactured by Delta
Mask, Toppan, Netherlands, using a GDSII layout file that was created using the Python platform
and gdsCAD 0.4.5 package containing the pattern designs; i.e., circle patterns with a diameter 50 µm.
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The photomask was washed with 70% ethanol and dried using absorption paper. The non-chrome
side of the photomask was silanated by placing it with the chrome side facing down in the UVO
cleaner and illuminating it for 10 min. The photomask was left to cool and then 10 µL millipore water
was placed onto the non-chrome surface of the mask. The coverslip with the activated face was then
placed on the drop of millipore water in contact with the photomask. Excess water was removed
using absorbent paper. The photomask was placed with its chrome side towards the lamp in the UVO
cleaner and illuminated for 10 min. Next, the mask was left to cool down and then submerged in
millipore water with the chrome side facing down (the coverslip facing upwards) until the coverslip
spontaneously started to lift off. The coverslip was carefully removed to avoid scratching the mask
and placed on a 70 µL drop of fibronectin solution (25 µg/mL fibronectin (Sigma, Johannesburg,
South Africa, F1141), 100 mM NaHCO3, pH 8.5.) on parafilm with the illuminated surface in contact
with the solution and incubated for 2 h at room temperature. Thereafter the coverslip was washed
for 2 min in millipore water and then dried overnight at 4 degrees and glued to the microscope slide
fabricated from acetal. Cells were harvested by trypsinisation and 1000 cells were added to each
well and placed in the incubator for 1–2 h to allow them to adhere. Thereafter, unattached cells were
washed off using culture media.
2.3. Treatment Conditions
A cocktail of fluorescent probes was prepared containing 75 nM LysoTracker Blue (ThermoFisher,
Johannesburg, South Africa, L7525) and 100 nM SiR-tubulin (SpiroChrome, Stein am Rhein, Switzerland,
CY-SC002) in culture media. Media was refreshed with culture media containing the dyes and
the respective drugs; 10 nM Bafilomcyin (LKT labs, B0026), 200 nM Rapamycin (Sigma, R8781)
and 20 nM Spermidine (Sigma, S2626). For autophagic flux analysis, saturating concentrations
of Bafilomycin (400 nM) were utilized, and autophagosome pool size quantified as previously
described [21]. Cells were treated for 8 h and then either imaged or harvested for western blot analysis.
2.4. Live Cell Imaging
Slides containing MEF cells were placed in a humidified chamber at 37 ◦C supplemented with
5% CO2 that encases the stage of the Carl Zeiss (Oberkochen, Germany) LSM780 P.S.1 microscope.
The raw image series was acquired using a high NA objective (Olympus Plan APO N 60×/1.42 Oil/
0.17/FN26.5) with 20 image acquisition cycles in 15 s intervals. An Argon multiline laser 25 mW at
488 nm and Diode 405 nm CW/PS and 633 nm laser were used as light source in combination with a
GaAsP detector. Laser power and master gain were chosen for 405 nm (LysoTracker blue), 488 nm
(GFP) and 633 nm (SiR Tubulin) to ensure an optimal signal/noise ratio with minimal saturation using
MBS: MBS 488/561/633 and MBS_InVis: MBS 405 beam splitters. Track filters were set as follows;
LysoTracker: 410–471 nm, GFP: 490–597 and SiR Tubublin: 638–759 nm.
2.5. Image Analysis
Images were processed using ZEN 2011 imaging software (Carl Zeiss, Oberkochen, Germany) and
exported to an automated puncta counting and tracking software, ImageJ with TrackMate plug-in [24],
for analysis.
We analysed the positions and motion of tracked, fluorescently labelled autophagosome puncta
for two cells, one circularly patterned (MP) and the second not patterned (NP). For the circularly
patterned cell 323 individual puncta were tracked over 7 median number of consecutive frames,
whereas the NP-dataset had 340 puncta over 13 median number of frames.
A potential source of differing behaviours in these two cases is the underlying arrangement of
microtubules, as is known from stiff confined filaments. In a disk-like structure, a natural point of
reference is the centre. We introduce quantities to discriminate whether the motions of puncta are
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mainly radial (towards or away from the centre) or perpendicular to the radial vector (i.e., parallel to
the boundaries). This measure of order depends on puncta positions and velocities
Q =
1
N(S) ∑n ∈ S
(1− 2 ( rˆn · vˆn) 2) (1)
where the sum is over a set of N(S) puncta S, rˆn represents the unit vector from a fixed reference point
to the punctum n, and vˆi the velocity vector of the punctum (calculated by comparing positions of
the same punctum at different frames/time-steps). For particles which move on average isotropically
Q = 0, whereas particles moving mainly towards or away from the central reference position would
show a Q < 0. Q is positive for motion that is perpendicular to the radial vector. The maximum of Q is
1 and its minimum −1.
We also determined the radial current and the average radial component of the velocity per
punctum via
I = − ∑
n ∈ S
rˆn ·→v n, i = − 1N(S) ∑n ∈ S
rˆn ·→v n. (2)
These quantities are positive for inward net flow.
For the circularly patterned cell (MP) 323 individual puncta were tracked over 7 median number
of consecutive frames, whereas the NP-dataset had 340 puncta over 13 median number of frames.
The central reference point (in each case) was determined by calculating the centre of mass of all
individual particles at the initial time measured. The farthest distance from this centre in MP was
24.1 units and in NP 57.5 units.
2.6. Western Blot Analysis
For protein extraction, culture medium was removed and cells were rinsed twice with cold PBS.
300 µL of RIPA buffer (50 mM Tris-HCl, 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM
EDTA, 1 mM PMSF, 1 mM Na3VO4, 1 mM NaF, 1 µg/mL leupeptin, 1 µg/mL aprotonin, 1 µg/mL
benzamidine, 10 µg/mL pepstatin, pH 7.4) were added per flask and cells scraped off using a cell
scraper (Porvair, WhiteSci, Brackenfell, South Africa, 500034). Lysates were collected and sonicated
on ice using a Misonix (Fisher Scientific, Loughborough, UK, S-4000), and centrifuged at 8000 rpm at
4 ◦C for 10 min (Labnet International, Edison, NJ, USA, Spectrafuge 16M). Supernatant was collected
and stored at −80 ◦C. A Bradford protein assay was used to determine the protein concentration of
the lysates. For western blotting 40 µg of protein was mixed with Laemmli buffer (6.5 mM Tris-HCl,
2% sodium dodecyl sulphate, 5% mercaptoethanol, 10% glycerol, 0.01% Bromophenol blue, pH 6.8)
in a 2:1 ratio and boiled at 95 ◦C for 5 min. Proteins were separated on a 12% TGX™ FastCast™
polyacrylamide gel (Bio-rad, Johannesburg, South Africa, 1610174) and transferred onto a Transfer
Pack PVDF membrane (Bio-rad, 170-84156) using Trans-Blot Turbo (Bio-rad, 170-4155). Membranes
were blocked with 5% milk in TBS-T (137 mM NaCl, 20 mM Tris, 0.1% Tween-20, pH 7.6) for 1 h.
Thereafter membranes were washed with TBST three times for 5 min and incubated with primary
antibodies overnight at 4 ◦C. The primary antibodies used were rabbit anti-LC3 (Sigma, L-8918 and
anti-Sequestosome1/p62 (Abcam, Pretoria, South Africa, ab-56416). Membranes were rinsed with TBST
three times for 5 min and then incubated with peroxidase-linked anti-rabbit IgG (Sigma, A-0545) for
one hour at room temperature and visualized using Clarity Western ECL substrate and the ChemiDoc
System (Bio-rad).
2.7. Statistical Analysis
Statistical analysis was performed using Statistica (13.0) using a one-way ANOVA and Bonferoni
correction as well as LSD Post-Hoc tests where p < 0.05 was considered significant.
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3. Results
3.1. Precision Control of Autophagic Flux—Achieving Similar Autophagic Activity Via mTOR Dependent and
Independent Pathway Induction
Single cell analysis enables to precisely dissect the relationship between autophagic flux and
autophagy pathway intermediates vesicle dynamics. In order to assess the role of increased autophagic
flux on vesicle dynamics, their motion and directionality, an experimental condition was implemented
that achieved similar autophagic activity using two different autophagy inducers, using non-patterned
and patterned cells.
Autophagosome flux was determined using the non-patterned cells, which were treated
after 2 hrs with the respective autophagy modulating drugs, followed by complete inhibition of
autophagosome/lysosome fusion with saturating concentrations of bafilomycin 9 h later (Figure 1).
These results demonstrate that firstly with all autophagy modulating drugs, a new steady state was
established after 6 h treatment intervention, which was indicated by no net change in the autophagy
pathway intermediates. Secondly, both autophagy inducing drugs, i.e., 200 nM rapamycin and 20 nM
spermidine resulted in an equal response in magnitude, resulting in a similarly enhanced autophagic
flux (∆J ≈ 100%) raising from 20.6 A/h at basal levels to 42.2 A/h and 38.6 A/h respectively under
induced conditions.
Moreover, our results show that both rapamycin and spermidine raised autolysosomal pool size
nAL from a basal pool of 73.5± 0.62 autolysosomes/cell to 94.4± 0.4 and 96± 1.23 autolysosomes/cell,
suggesting that increased autophagosome flux manisfests largely in a change of the autolysosomal pool.
Of note, only partial inhibition with 10 nM bafilomycin led to a distinct increase in the autophagosomal
pool size (Figure 1B), however, with no change in autophagosome flux compared to non-treated control
cells. These data indicate, that the same increased autophagosome flux can be achieved using mTOR
dependent and independent pathway targeting strategies. These conditions were hence used for
subsequent experiments.
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Figure 1. In order to assess autophagosome flux, the pathway intermediates were plotted in time. Flux response analysis using autophagy modulating drugs reveals 
a similarly enhanced autophagosome flux using 200 nM rapamycin (C) and 20 nM spermidine (D) compared to control conditions (A), with a new steady state flux 
established 6 h into the treatment time (blue vertical line). Note, low concentrations of bafilomycin lead to a change in pathway intermediate pool size (B), without 
impacting basal autophagosome flux. A total of 20 cells have been analysed. 
Figure 1. In order to assess autophagosome flux, the pathway intermediates were plotted in time. Flux response analysis using autophagy modulating drugs reveals a
similarly enhanced autophagosome flux using 200 nM rapamycin (C) and 20 nM spermidine (D) compared to control conditions (A), with a new steady state flux
established 6 h into the treatment time (blue vertical line). Note, low concentrations of bafilomycin lead to a change in pathway intermediate pool size (B), without
impacting basal autophagosome flux. A total of 20 cells have been analysed.
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3.2. Precision Control of Cell Size and Tubulin Network—Assessment of Pool Sizes and Vesicle Trafficking
We evaluated the role of increased autophagosome flux on pathway intermediates,
autophagosome velocity and displacement, using non-patterned and patterned cells (Figure 2) in order
to control cellular geometry. Micropatterning resulted in a precise cellular size, a highly ordered cellular
architecture with a distinctly organized tubulin network characterised by a high degree of symmetry
(Figure 2A) and a primarily perinuclear distribution of autophagosomes and lysosomes. Non-patterned
cells, on the other hand, displayed a completely asymmetrical tubulin network architecture with a
wider distribution spectrum of autophagosomes and lysosomes throughout the cytoplasm and cellular
processes (Figure 2B).
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analysis  following  autophagy  induction  revealed  at  steady  state  a  significant  increase  in  LC3‐II 
protein levels only in the rapamycin treatment group compared to control conditions (Figure 3A)., 
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3A). 
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Figure 2. In order to enhance experimental control and to include geometry constraints, allowing
to assess the contribution of tubulin organisation to autophagy pool size and vesicle dyna ics,
micropatterning was utilized. icropatterned cells (A) display primarily perinuclear and branched
organisation of autophagy pathway intermediates and a highly ordered tubulin network, while
non-patterned cells (B) are characterized by a wide and asymmetric cytoplasmic distribution profile of
autophagy pathway intermediates.
lt ough fl x ce ent as si ilar e i ci r i i e, ster l t
alysis f llo ing autophagy induction revealed at steady state a si ifica t i crease i -II
r t i l ls l i t ci treat ent group co pared to control conditions (Figure 3A).,
l t p62 protein levels decreased only upon rapa ycin treat ent, and i crease
s r i t as wel as partial inhibition using low concentra ions of bafilomycin (Figure 3A).
These data are supported by the quantitative assessment of pathway intermediates (Figure 3B) as
well as the fluorescence micrograp s (Figure 3C and Figure S1), depicting a si ilar sc nar o, where
similar flux s n t necessarily eflect in equal steady state p otein levels of LC3-II and p62. They may
also reflect that the turnover ate of autolyso omes may affect the protein levels of LC3-II, although
the pool sizes of autophagosomes, l es and lysosomes were similar in both autophagy
inducing conditions (Figure 3B). Inducti n of autophagy led to a significant increase in autolysosomes
when using rapamycin and spermidine in on-patterned as well as patterned cells (Figure 3B).
Micropatterned cells displayed an enhanced r solution i dissecting the ly osome pool size, which
decreased upon a mycin treatment, but not so i the spermidine treate cells. Colocalisation analysis
of microtubule signal and autophagosomes indicates an equal network occu ancy, with no differences
under non-patterned or treatment conditio s (Figure S2), however, rapamycin treatment appears
to increase colocalisation area and occupancy in patterned cells. Moreover, overall autophagosome
size appears to be larger in the rapamycin-treated cells, compared to autophagosomes observed in
spermidine exposed cells (Figure S1).
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Figure 3. LC3-I/II as well as p62 protein expression levels (A) upon autophagy induction, using
rapamycin or spermidine, as well as partial inhibition, using non-saturating concentrations of
bafilomycin. A representative blot is shown. A minimum of three independent experiments (n = 3)
were performed. Autophagy pathway intermediate pool size quantification (B) and representative
micrographs (C) of non-patterned and patterned cells.
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3.3. Precision Control of Cell Size and Tubulin Network—Assessment of Autophagosome Trafficking
To our surprise, velocity and displacement analysis revealed distinct differences between treatment
modalities as well as non-patterned and patterned cells. Non-patterned cells were characterized by a
significantly increased autophagosome mean velocity upon spermidine treatment (Figure 4A) compared to
control cells as well as cells treated with rapamycin. In contrast, patterned cells revealed a significantly
decreased mean velocity as well as mean displacement upon flux induction (Figure 4A) compared
to control conditions. Moreover, partial inhibition and residual autophagic flux did not lead to a
change in vesicle dynamics, remaining higher than those observed in the groups with enhanced
autophagic flux (Figure 4A). When assessing vesicle tracks according to highest and lowest velocity,
no distinct intracellular regional preference could be observed in both non-patterned and patterned
cells (Figure 4B).
These data suggest that increased autophagic flux not necessarily increases autophagosome
velocity or movement characteristics, in contrast, it may even decrease in conditions of geometry
constraints, even though concentration and duration of autophagy modulation remains similar.
Whether such response implicates functional protein degradation capacity, remains to be elucidated.
When assessing high versus low velocity tracks in patterned and non-patterned cells, no preferred
region of enhanced or decreased velocity is apparent (Figure 4B), suggesting that tubulin network
organisation relative to the perinuclear region and cellular size is unlikely implicated in governing
regional autophagosome velocity and displacement.
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Figure 4. Autophagosome velocity and displacement analysis (A) in patterned and non-patterned
cells upon autophagy induction, using rapamycin or spermidine, as well as partial inhibition, using
non-saturating concentrations of bafilomycin. Representative micrographs of low and high velocity
tracks (B) are indicated. A minimum of three independent experiments (n = 3) were performed.
3.4. Directionality of Autophagosome Motion
In order to assess the directionality of vesicle movement in non-patterned and patterned cells,
vector analysis was performed. For micropatterned cell, calculating the order measure for all time steps
of all puncta, we determine Q = −0.04 (with a large standard deviation 0.7). We see, in Figure 5A,
that average motion of autophagosomes in micropatterned cells has a weak trend to being radial
which becomes stronger towards the periphery. No such trends are noticeable for the non-patterned
cells. For this calculation the velocity of an autophagosome punctum was taken as the difference in
displacement vector between two consecutive time measurements.
Considering that between single consecutive tracking events (frames or time-steps) autophagosomes
typically only moved very small distances, we explored calculating velocity-dependent properties
of puncta using a larger time-step separation, enabling longer distances for average autophagic
punctum velocity determination, and less dependent on the system resolution. Of course, fewer
autophagosomes are tracked over a longer period of time, which lowers the number of puncta that
can be taken into account. The average radial velocity per autophagosome punctum tracked is
shown for the non-patterned and micropatterned cells in Figure 5B. Of note, for the initial time
frames autophagosomes in micropatterned and non-patterned cells seem to be moving in opposite
directions. Any distinctive inward or outward motion for puncta that can be tracked beyond 10 frames
is not discernible.
The quantity Qτ as a function τ is the number of frames from the initial frame over which the
particle is tracked. We have separated the MP sample into puncta captured within central, intermediate,
and peripheral regions. The data indicate that those puncta moving in the periphery, and that are
tracked for longer than approximately 10 time-steps, show rather distinctive behaviour of moving
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parallel to the confining boundary (indicated by a positive Qτ). This is not observed in the regions
closer to the centre, nor do we observe positive order when particles are tracked over short times. It is
to be noted that for small times τ, there are far greater numbers of puncta to be tracked. (please see
Supplementary Material.) The behaviour shown here is compatible with the current information of
Figure 5. We conclude that autophagosome puncta of micropatterned cells, which can be tracked over
a longer time show strong perpendicular ordering in the periphery. However, the far greater number of
puncta that can be tracked over shorter times move radially, or isotropically (Supplementary Material
Figures S3–S5). A similar behaviour is observed for autophagosome puncta in non-patterned cells,
suggesting a generic systems observation of perpendicular ordering.
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Figure 5. (A) Order measure Q as a function of radial distance for different segments of radius.
No trend is discernable for the non-patterned cells (NP), but a clear radial motion, albeit rather small,
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(C) Motion is mainly directed along the double-headed arrow line. A minimum of three independent
experiments (n = 3) were performed.
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4. Discussion
In this study we revealed three highly relevant phenomena concerning the dynamics and control of
the autophagy system. The first finding is that a precisely enhanced autophagic flux condition with two
different autophagy inducing drugs is possible. The second finding is that increased autophagic flux
through rapamycin and spermidine treatment decreases autophagosome velocity and displacement.
Finally, cellular and microtubule network geometry and physical constraints govern, at least in part,
the autophagy response, indicated by a differential autophagosome movement and motion pattern in
the central versus the peripheral intracellular region.
4.1. Autophagic Flux Control is Achievable
Although we have learnt about the autophagy machinery and its pathway regulation [25], and
despite the fact that we increasingly unravel the molecular defects of autophagy in disease [2], many
questions center around the tools and systems that assess the autophagic process accurately and
dynamically, so that fine-tuning of autophagic activity would become possible [26]. Here, we show,
to our knowledge for the first time, that the titration of enhanced autophagic flux using two drugs,
rapamycin and spermidine, is possible (Figure 1). Using single cell analysis and z-stack-based pool
size analysis [21], we are able to describe autophagosome flux at high resolution, allowing us to use a
drug concentration that achieves a similar autophagic flux. Other commonly used techniques, such
as western blotting (Figure 3), though providing valuable information about autophagy protein or
cargo autophagosome abundance, are less able to resolve changes in autophagosome abundance upon
bafilomycin treatment, and omit particular measurable indexes related to autophagic activity [27].
The implemented micropattern approach (Figure 2) further enhances the control over the cellular
environment, allowing accurate and repeatable pool size analyses. Hence, the use of life cell imaging
and single cell analysis-based fluorescence microscopy in assessing autophagic activity provides a
unique and powerful tool to finely describe changes in autophagy function and dysfunction, screening
libraries of autophagy modulating drugs, including spermidine and rapamycin [13,28–32]. Our results
show enhanced autophagic activity using rapamycin and spermidine, raising autophagic flux equally,
leading to an increase in respective pool size intermediates (Figure 3B,C). This is supported by
others [18], who have described an increase in autolysosmal pool size upon autophagy induction.
Great care must however be taken, to use saturating concentrations of a lysosomal inhibitor or
deacidifying agent, such as bafilomycin [21,33], to prevent the persistence of a residual autophagic
activity. Here, we utilized this scenario purposefully (Figures 1 and 3), to dissect the relationship
between autophagic flux and autophagy vesicle dynamics. Although this concept had been indicated
recently [20,21], the direct comparison of pathway intermediates between residual and enhanced
autophagic flux is of novelty (Figures 1 and 3). This is important, since a dissociation between
autophagy machinery function and cargo has been described [34], suggesting that, in addition
to autophagic flux assessment, the particular protein cargo requires equal attention, so as not to
miss dysfunction with the recognition of particular protein cargo species, but otherwise functional
autophagy machinery. Although not the focus of this study, we noted that, although rapamycin and
spermidine treatment equally enhanced autophagic activity based on the autophagosome pool size,
the organelle size appeared larger in the rapamycin treated cells (Figure 3 and Figure S1), suggesting
that cargo turnover may indeed be distinct. This deserves further attention in future studies, especially
when screening drugs for efficiency and magnitude in autophagy induction, since it may highlight two
major cellular control systems for tuning autophagic activity, through flux- as well as autophagosome
size control.
4.2. Enhanced Autophagic Flux Decreases Autophagosome Velocity
Neurons rely on a particularly effective autophagy machinery, to maintain proteostasis. Rapamycin
and spermidine have both been shown to induce autophagy in neurons, thereby enabling effective
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clearance of toxic protein aggregates, such as amyloid-ß and tau [14,31,32,35]. To our surprise, we show
that autophagy induction using rapamycin and spermidine leads a decrease in autophagosome velocity
and displacement (Figure 4A), which becomes particularly clear in the micropatterned cells. Partial
inhibition of autophagosomal/lysosomal fusion however leaves velocity parameters unaffected. This is
somewhat unexpected, since an increase in the turnover of the intracellular autophagosomal pool size
requires an efficient autophagosomal trafficking, to prevent molecular crowding and cargo aggregation.
Autophagosomes are dynein-dependently transported along the microtubulin network, which serves
as linear but dynamically unstable tracks to deliver cargo for lysosomal degradation [18,36]. It is
known that mutations affecting the dynein complex can lead to toxic protein aggregation. A decrease in
localized ATP seems unlikely, since increased autophagy may enhance metabolite substrate generation,
contributing to an energetically favorable environment [4]. In addition, also autophagosome formation
is dependent on the microtubule system [37]. Since only mature autophagosomes are recruited to the
microtubules [36], it is plausible that the maturation process and its control is implicated in the decrease
in velocity. Whether a change in local ATP availability contributes to these findings, remains to be
elucidated. Further studies will be necessary, to delineate the exact relationship between autophagic
flux, ATP consumption and autophagosome transport properties. As successful aging is associated
with a preserved functional protein degradation system, the molecular underpinnings that govern
functional autophagosome transport for subsequent lysosomal fusion require further attention.
4.3. Cell Morphology and Tubulin Network Geometry Influence Autophagosome Motion
The efficient encounter of autophagosomes with lysosomes is critical in facilitating protein
degradation through autophagy. Hence, positioning of autophagy pathway intermediates as well as
their pool sizes impacts on the probability for successful encounter of fusion partners. Our results
highlight a differential autophagosome motion and directionality, when comparing patterned and
non-patterned cells, with a clear radial motion of autophagosomes in patterned cells (Figure 5A), which,
unlike in non-patterned cells, move initially towards the edge of the cell (Figure 5B). This intriguing
finding highlights that cellular and microtubule network geometry and physical constraints govern,
at least in part, the autophagy response. It is known that autophagosomes are formed in the
cytosol, distant to lysosomes [38], and move towards the perinuclear region in a linear translocation
pattern [36,39]. Micropatterning-induced microtubule organisation however, changes this pattern,
strongly supporting the notion that cytoskeletal filaments, that are confined, lead to insights that a
particular geometry and confinement plays an important role in vesicle dynamics [40,41]. This is
of importance, given that cells forming a neuronal network of distinct susceptibility to protein
aggregation [31] or a solid tumour microenvironment [42] may be characterized by inherent geometry
constraints which may have an influence on the region-specific autophagic activity and response
to autophagy modulation. Continued progress on the assessment of the relationship between
autophagosome motion and directionality in context of lysosomal fusion will undoubtedly provide
insights that unravel conditions of autophagy induction that will most profoundly favor functional
protein degradation.
Taken together, it becomes clear that the precision control of autophagic activity requires
the careful quantitative assessment of multiple molecular and biophysical parameters that govern
functional autophagy and protein degradation. Autophagy pathway intermediate pool sizes, their
positioning, their rate of fusion, motion and velocity all in the context of cellular geometry and
confinement contribute to the cell’s proficiency to degrade long-lived proteins and contribute to the
upkeep of proteostasis. These findings may be of importance when screening for drugs intended to
fine-tune autophagic activity therapeutically, in conditions of autophagy failure in different cell and
tissue types of age-associated pathologies. Hence, the utilisation of human as well as differentiated
cells will be critical for future applications.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4409/7/8/94/s1,
Figure S1: Timelapse micrographs indicating distinct pool size distribution in patterned and non-patterned cells
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upon autophagy induction, using rapamycin or spermidine, as well as partial inhibition, using non-saturating
concentrations of bafilomycin; Figure S2: Colocalisation analysis (a) indicating colocalisation of autophagosomes
with the microtubule network. Micrographs indicating colocalisation profile in patterned and non-patterned cells
(b) upon autophagy induction, using rapamycin or spermidine, as well as partial inhibition, using non-saturating
concentrations of bafilomycin; Figure S3: (a) Histogram for number of particles trackable up to exactly time
step τ. Dataset micropatterned cells, (b) Histogram for number of particles trackable up to exactly time step τ.
Dataset non-patterned cells; Figure S4: (a) Plot of ln
√
R2 vs. ln τ for micropatterned cells, with the dashed line to
indicate the ideal random walk scaling. Note, that the presence of such scaling is not sufficient evidence for a
random walk, (b) Plot of ln
√
R2 vs. ln τ for micropatterned cells, with the dashed line to indicate the ideal random
walk scaling. Note, that the presence of such scaling is not sufficient evidence for a random walk; Figure S5:
(a) Order measure for puncta of dataset micropatterned cells, where data are collected over tracks spanning at least
τ time-steps. For tracks of longer duration strong order is noticeable in the region near the periphery. Here the
maximum distance is taken as 30 units, (b) Order measure for puncta of dataset non-patterned cells, where data
are collected over tracks spanning at least τ time-steps. For tracks of longer duration strong order is noticeable in
the region near the periphery. Here the maximum distance is taken as 60 units.
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